Alkermes Plc reports results for the quarter ended in January - Earnings Summary

Alkermes

24/07/2024 14:31

* Alkermes Plc  ALKS.OQ  reported quarterly adjusted
earnings of
70 cents​​ per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of 55 cents.  The mean expectation of eleven analysts for the
quarter was for earnings of 70 cents per share. Wall Street
expected results to range from 60 cents to 85 cents per share.
    * Revenue fell 35.4% to $399.10 million from a year ago;
analysts
expected $393.35 million. 
    * Alkermes Plc's reported EPS for the quarter was 53 cents​.
    * The company reported quarterly net income of $91.4
million.
    * Alkermes Plc shares had risen by 3.7% this quarter and
lost 9.9%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.7%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Alkermes Plc is
$34.50 
This summary was machine generated from LSEG data July 24 at
01:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.70           0.70           Met
 Mar. 31 2024      0.58           0.43           Missed
 Dec. 31 2023      0.51           0.22           Missed
 Sep. 30 2023      0.44           0.64           Beat